Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Junshang Ge
The BRAF V600E Mutation Is a Predictor of the Effect of Radioiodine Therapy in Papillary Thyroid Cancer
Journal of Cancer
Oncology
Related publications
Prognostic Utility of BRAF Mutation in Papillary Thyroid Cancer
Molecular and Cellular Endocrinology
Biochemistry
Endocrinology
Molecular Biology
Redifferentiation of Iodine-Refractory BRAF V600e-Mutant Metastatic Papillary Thyroid Cancer With Dabrafenib
Clinical Cancer Research
Cancer Research
Oncology
Radioiodine Therapy of Papillary Thyroid Cancer, Complicated by a Radial Myelitis. Clinical Case
The Russian Archives of Internal Medicine
Targeted Treatment of Papillary Craniopharyngiomas Harboring BRAF V600E Mutations
Cancer
Cancer Research
Oncology
Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients With Acromegaly
PLoS ONE
Multidisciplinary
Newly Diagnosed Papillary Craniopharyngioma With BRAF V600E Mutation Treated With Single-Agent Selective BRAF Inhibitor Dabrafenib: A Case Report
Oncotarget
Oncology
Radiomics Study of Thyroid Ultrasound for Predicting BRAF Mutation in Papillary Thyroid Carcinoma: Preliminary Results
American Journal of Neuroradiology
Medicine
Nuclear Medicine
Neurology
Imaging
Radiology
Immunohistochemistry With Anti-Braf V600E (VE1) Mouse Monoclonal Antibody Is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases With and Without KRAS Mutation and Literature Review
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Is Radioiodine Administration in Patients With Papillary Thyroid Multifocal Microcarcinoma Unnecessary?
Endocrinology, Diabetes and Metabolism Case Reports
Internal Medicine
Endocrinology
Metabolism
Diabetes
